PUR.WA Stock - Pure Biologics Spólka Akcyjna
Unlock GoAI Insights for PUR.WA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $95,000 | $662,000 | $254,000 | $572,000 |
| Gross Profit | $-46,000 | $-2,574,000 | $-5,407,000 | $-4,027,000 | $299,000 |
| Gross Margin | N/A | -2709.5% | -816.8% | -1585.4% | 52.3% |
| Operating Income | $-12,383,000 | $-31,718,000 | $-24,629,000 | $-10,482,000 | $-11,556,000 |
| Net Income | $-19,435,000 | $-35,694,000 | $-26,372,000 | $-13,071,000 | $-12,105,000 |
| Net Margin | N/A | -37572.6% | -3983.7% | -5146.1% | -2116.3% |
| EPS | $-3.78 | $-11.19 | $-11.87 | $-5.88 | $-7.32 |
Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis. Pure Biologics Spólka Akcyjna was founded in 2010 and is headquartered in Wroclaw, Poland.
Visit WebsiteEarnings History & Surprises
PUR.WAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 30, 2023 | — | $-2.36 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-3.22 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-2.53 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-2.93 | — | — |
Latest News
Frequently Asked Questions about PUR.WA
What is PUR.WA's current stock price?
What is the analyst price target for PUR.WA?
What sector is Pure Biologics Spólka Akcyjna in?
What is PUR.WA's market cap?
Does PUR.WA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PUR.WA for comparison